SG60886G - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
SG60886G
SG60886G SG608/86A SG60886A SG60886G SG 60886 G SG60886 G SG 60886G SG 608/86 A SG608/86 A SG 608/86A SG 60886 A SG60886 A SG 60886A SG 60886 G SG60886 G SG 60886G
Authority
SG
Singapore
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Application number
SG608/86A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of SG60886G publication Critical patent/SG60886G/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG608/86A 1979-03-27 1986-07-10 Therapeutic agents SG60886G (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27
GB7939505 1979-11-15

Publications (1)

Publication Number Publication Date
SG60886G true SG60886G (en) 1987-03-27

Family

ID=26271029

Family Applications (1)

Application Number Title Priority Date Filing Date
SG608/86A SG60886G (en) 1979-03-27 1986-07-10 Therapeutic agents

Country Status (34)

Country Link
US (1) US4302460A (da)
KR (1) KR840001612B1 (da)
AT (1) AT379390B (da)
AU (1) AU536616B2 (da)
BG (2) BG37836A3 (da)
CA (1) CA1151652A (da)
CH (1) CH644366A5 (da)
CS (1) CS221906B2 (da)
DD (1) DD149608A5 (da)
DE (2) DE3011994A1 (da)
DK (1) DK151252C (da)
EG (1) EG16606A (da)
FI (1) FI77026C (da)
FR (2) FR2452484A1 (da)
GR (1) GR68007B (da)
HK (1) HK94986A (da)
HU (1) HU179845B (da)
IE (1) IE49562B1 (da)
IL (1) IL59710A (da)
IT (1) IT1188916B (da)
KE (1) KE3649D (da)
LU (1) LU82295A1 (da)
MX (1) MX6816E (da)
MY (1) MY8600668A (da)
NL (1) NL191306C (da)
NO (1) NO156787C (da)
NZ (1) NZ193167A (da)
PH (1) PH16758A (da)
PL (1) PL124037B1 (da)
PT (1) PT71006A (da)
RO (1) RO79397A (da)
SE (1) SE455422B (da)
SG (1) SG60886G (da)
YU (1) YU42332B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
DE3578374D1 (de) * 1984-01-13 1990-08-02 Boots Co Ltd Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
GB8515209D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8515207D0 (en) * 1985-06-15 1985-07-17 Boots Co Plc Therapeutic agents
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
GB8918952D0 (en) * 1989-08-19 1989-10-04 Boots Co Plc Therapeutic agents
FR2680511B1 (fr) * 1991-08-20 1995-05-19 Roussel Uclaf Derives n-substitues de la quinoleine, leur procede de preparation, intermediaires obtenus, leur application comme medicaments et les compositions les renfermant.
FR2672597B1 (fr) * 1991-02-07 1995-05-19 Roussel Uclaf Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2684671B1 (fr) * 1991-11-20 1995-05-19 Roussel Uclaf Nouveaux derives de la quinoleine, leur procede de preparation et intermediaires et leur application a titre de medicaments.
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
JP2002522388A (ja) * 1998-08-03 2002-07-23 ビーエーエスエフ コーポレーション 性機能障害の治療のためのピリジノン
US6307050B1 (en) * 2000-08-29 2001-10-23 R. T. Alamo Venture I Llc Method of synthesizing flosequinan from 4-fluoroanthranilic acid
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6649764B2 (en) * 2001-10-25 2003-11-18 R. T. Alamo Ventures I, Llc Stereospecific enrichment of heterocyclic enantiomers
US6730790B2 (en) * 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1066919A (en) 1964-04-03 1967-04-26 Hoffmann La Roche Novel benzyl amine derivatives
DE1770482A1 (de) * 1968-05-22 1971-11-11 Basf Ag Verfahren zur Herstellung von 2,4-Dioxychinolinen
US3798219A (en) * 1971-10-18 1974-03-19 Warner Lambert Co 3-(methylsulfinyl)cinnolinones and their derivatives
US3772301A (en) * 1971-11-22 1973-11-13 Warner Lambert Co (4-substituted)4-(methylsulfinyl)methylcarbostyrils
CH607848A5 (da) * 1974-06-04 1978-11-30 Bayer Ag
GB1488411A (en) * 1975-01-16 1977-10-12 Wyeth John & Brother Ltd 3,4-dihydro-4-arylquinolin-4-ol derivatives
US4124587A (en) * 1976-03-01 1978-11-07 Sandoz, Inc. 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones
US4127574A (en) * 1976-03-01 1978-11-28 Sandoz, Inc. 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones
DE2616995A1 (de) 1976-04-17 1977-10-27 Bayer Ag 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2616991A1 (de) 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639257A1 (de) 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2639498A1 (de) 1976-09-02 1978-03-09 Bayer Ag Neue schwefelhaltige amino-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2641746C2 (de) 1976-09-16 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-Zuckerderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658804A1 (de) 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
DE2715182A1 (de) 1977-04-05 1978-10-19 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5424882A (en) 1977-07-22 1979-02-24 Yamanouchi Pharmaceut Co Ltd Novel heterocyclic compounds and their preparation
DE2747513A1 (de) 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen

Also Published As

Publication number Publication date
DE3011994C2 (da) 1991-06-27
CS221906B2 (en) 1983-04-29
US4302460A (en) 1981-11-24
PL223050A1 (da) 1981-01-30
IT8048262A1 (it) 1981-09-26
IT8048262A0 (it) 1980-03-26
YU84980A (en) 1983-09-30
IE49562B1 (en) 1985-10-30
HK94986A (en) 1986-12-12
IT1188916B (it) 1988-01-28
FR2468367A1 (fr) 1981-05-08
FI800923A (fi) 1980-09-28
DE3011994A1 (de) 1980-10-16
NO156787C (no) 1987-11-25
AT379390B (de) 1985-12-27
DD149608A5 (de) 1981-07-22
KR830001898A (ko) 1983-05-19
DK151252B (da) 1987-11-16
GR68007B (da) 1981-10-26
AU5670280A (en) 1980-10-02
ATA161880A (de) 1985-05-15
NZ193167A (en) 1984-08-24
MX6816E (es) 1986-08-05
FR2468367B1 (da) 1983-09-30
NL8001771A (nl) 1980-09-30
LU82295A1 (fr) 1981-04-17
NL191306B (nl) 1994-12-16
FR2452484B1 (da) 1983-08-12
KR840001612B1 (ko) 1984-10-11
PH16758A (en) 1984-02-15
RO79397A (ro) 1982-06-25
DK130180A (da) 1980-09-28
EG16606A (en) 1989-01-30
CH644366A5 (fr) 1984-07-31
KE3649D (en) 1986-08-01
NO800881L (no) 1980-09-29
YU42332B (en) 1988-08-31
SE455422B (sv) 1988-07-11
MY8600668A (en) 1986-12-31
BG37836A3 (en) 1985-08-15
FI77026B (fi) 1988-09-30
IL59710A (en) 1984-01-31
FR2452484A1 (fr) 1980-10-24
HU179845B (en) 1982-12-28
FI77026C (fi) 1989-01-10
CA1151652A (en) 1983-08-09
IE800567L (en) 1980-09-27
DK151252C (da) 1988-05-16
BG37993A3 (en) 1985-09-16
PT71006A (en) 1980-04-01
DE3051205C2 (de) 1991-01-24
NL191306C (nl) 1995-05-16
PL124037B1 (en) 1982-12-31
AU536616B2 (en) 1984-05-17
NO156787B (no) 1987-08-17
SE8002345L (sv) 1980-11-14

Similar Documents

Publication Publication Date Title
PH15198A (en) Therapeutic agents
GB2000136B (en) Therapeutic agents
GB2005248B (en) Therapeutic agents
ZA782816B (en) Therapeutic agents
ZA80298B (en) Therapeutic agents
GB2000138B (en) Therapeutic agents
ZA796708B (en) Therapeutic agents
GB2000131B (en) Therapeutic agents
EG16606A (en) Therapeutic agents
ZA792390B (en) Therapeutic agents
GB2013181B (en) Therapeutic agents
GB2004876B (en) Therapeutic agents
GB2007656B (en) Therapeutic agents
GB2019836B (en) Therapeutic agents
GB2047691B (en) Therapeutic agents
GB2053910B (en) Pyridylaminotriazole therapeutic agents
GB2000510B (en) Therapeutic agents
GB2011890B (en) Therapeutic agents
GB2010824B (en) Therapeutic agents
GB2013179B (en) Therapeutic agents
GB2011891B (en) Therapeutic agents
GB2007654B (en) Therapeutic agents
GB2008104B (en) Therapeutic agents
ZA803988B (en) Novel therapeutic combinations
GB2000441B (en) Therapeutic agents